IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $265,191 | -19.9% | 27,538 | -11.4% | 0.16% | -17.9% |
| Q2 2023 | $330,872 | +26.6% | 31,097 | +25.2% | 0.20% | +36.1% |
| Q1 2023 | $261,296 | -13.6% | 24,838 | +1.8% | 0.14% | -8.9% |
| Q4 2022 | $302,304 | +41.9% | 24,399 | +18.6% | 0.16% | +85.9% |
| Q3 2022 | $213,000 | -9.0% | 20,570 | +1.5% | 0.08% | -2.3% |
| Q2 2022 | $234,000 | -45.3% | 20,267 | -40.5% | 0.09% | -54.7% |
| Q1 2022 | $428,000 | +7.8% | 34,062 | 0.0% | 0.19% | +28.0% |
| Q4 2021 | $397,000 | -25.2% | 34,062 | -16.3% | 0.15% | -35.9% |
| Q3 2021 | $531,000 | -7.2% | 40,695 | -8.4% | 0.23% | -0.4% |
| Q2 2021 | $572,000 | -0.3% | 44,421 | -13.4% | 0.24% | -2.9% |
| Q1 2021 | $574,000 | +1.1% | 51,311 | +2.8% | 0.24% | +2.5% |
| Q4 2020 | $568,000 | -1.2% | 49,908 | -22.0% | 0.24% | -21.9% |
| Q3 2020 | $575,000 | -4.8% | 63,946 | +9.2% | 0.30% | +5.6% |
| Q2 2020 | $604,000 | +30.2% | 58,560 | +27.3% | 0.29% | +49.7% |
| Q1 2020 | $464,000 | -30.1% | 46,003 | -7.8% | 0.19% | +75.2% |
| Q4 2019 | $664,000 | +15.7% | 49,885 | -25.3% | 0.11% | -6.0% |
| Q3 2019 | $574,000 | -32.8% | 66,816 | -14.4% | 0.12% | -35.6% |
| Q2 2019 | $854,000 | -8.3% | 78,060 | +13.4% | 0.18% | -90.9% |
| Q1 2019 | $931,000 | +70.2% | 68,811 | +30.3% | 1.98% | +2030.1% |
| Q4 2018 | $547,000 | -29.7% | 52,822 | +25.4% | 0.09% | +16.2% |
| Q3 2018 | $778,000 | +3.6% | 42,130 | +7.2% | 0.08% | -88.0% |
| Q2 2018 | $751,000 | -17.6% | 39,291 | -33.4% | 0.66% | -15.9% |
| Q1 2018 | $911,000 | -2.8% | 59,014 | -5.6% | 0.79% | -32.8% |
| Q4 2017 | $937,000 | +1.8% | 62,500 | +7.1% | 1.18% | +848.4% |
| Q3 2017 | $920,000 | -16.5% | 58,346 | 0.0% | 0.12% | -24.4% |
| Q2 2017 | $1,102,000 | -2.4% | 58,346 | -11.8% | 0.16% | -18.4% |
| Q1 2017 | $1,129,000 | +23.5% | 66,160 | +10.6% | 0.20% | -26.4% |
| Q4 2016 | $914,000 | +19.0% | 59,798 | +23.6% | 0.27% | -26.4% |
| Q3 2016 | $768,000 | +38.9% | 48,372 | +14.4% | 0.37% | -9.5% |
| Q2 2016 | $553,000 | -6.0% | 42,277 | -21.4% | 0.41% | -49.4% |
| Q1 2016 | $588,000 | – | 53,788 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |